Literature DB >> 10089378

Crystallization of hepatitis B virus core protein shells: determination of cryoprotectant conditions and preliminary X-ray characterization.

S A Wynne1, A G Leslie, P J Butler, R A Crowther.   

Abstract

Hepatitis B virus causes liver cirrhosis and hepatocellular cancer and is a major cause of death, particularly in Asia and sub-Saharan Africa. The virus consists of an inner core or nucleocapsid, which encloses the viral nucleic acid, with an outer lipid envelope containing surface-antigen proteins. The core protein, when expressed in E. coli, assembles into spherical shells containing 180 or 240 subunits, arranged with T = 3 or T = 4 icosahedral symmetry. The C-terminal region of the protein is involved in nucleic acid binding, and deletion of this region does not prevent capsid formation. C-terminally deleted hepatitis B core shells containing 240 subunits have been crystallized and data has been collected to 3. 6 A resolution from frozen crystals, using butanediol as a cryoprotectant. The crystals have C2 symmetry, with unit-cell parameters a = 538.0, b = 353.0, c = 369.6 A, beta = 132.3 degrees.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10089378     DOI: 10.1107/s0907444998012621

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  3 in total

1.  Conformational Plasticity of Hepatitis B Core Protein Spikes Promotes Peptide Binding Independent of the Secretion Phenotype.

Authors:  Cihan Makbul; Vladimir Khayenko; Hans Michael Maric; Bettina Böttcher
Journal:  Microorganisms       Date:  2021-04-29

2.  Structures of hepatitis B virus cores presenting a model epitope and their complexes with antibodies.

Authors:  A M Roseman; O Borschukova; J A Berriman; S A Wynne; P Pumpens; R A Crowther
Journal:  J Mol Biol       Date:  2012-06-28       Impact factor: 5.469

3.  Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids.

Authors:  Christopher John Schlicksup; Joseph Che-Yen Wang; Samson Francis; Balasubramanian Venkatakrishnan; William W Turner; Michael VanNieuwenhze; Adam Zlotnick
Journal:  Elife       Date:  2018-01-29       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.